Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sigyn Therapeutics Inc (SIGY)

Sigyn Therapeutics Inc (SIGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,043
  • Shares Outstanding, K 1,225
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,150 K
  • 60-Month Beta -1.68
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SIGY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.80
  • Most Recent Earnings $-0.80 on 11/14/23
  • Latest Earnings Date 05/21/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.5000 +27.78%
on 03/26/24
6.2500 -8.00%
on 04/12/24
+0.7500 (+15.00%)
since 03/05/24
3-Month
3.0000 +91.67%
on 02/02/24
7.9600 -27.76%
on 01/30/24
+1.7500 (+43.75%)
since 01/19/24
52-Week
2.0800 +176.44%
on 06/20/23
12.8000 -55.08%
on 08/25/23
+0.5980 (+11.61%)
since 04/04/23

Most Recent Stories

More News
Sigyn Therapeutics to Commence Trading on the OTCQB® Venture Exchange

SAN DIEGO, CA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY), a development-stage medical technology...

OTC.VN : 0.340 (-1.45%)
SIGY : 6.3400 (+10.26%)
Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board

SAN DIEGO, CA, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused...

SIGY : 6.3400 (+10.26%)
Sigyn Therapeutics™ Appoints H. David Humes, MD to Its Scientific Advisory Board

SAN DIEGO, CA, March 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused...

SIGY : 6.3400 (+10.26%)
Sigyn Therapeutics to Present at the Bullseye Small Cap Virtual Investor Conference

SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on...

SIGY : 6.3400 (+10.26%)
Sigyn Therapeutics Announces Presentation at Today’s Emerging Growth Conference

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets: “SIGY”), a medical technology company focused on...

SIGY : 6.3400 (+10.26%)
Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or Vaccines

SAN DIEGO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on...

SIGY : 6.3400 (+10.26%)
Sigyn Therapeutics Reports the Successful Completion of a Study to Address Gram-Positive Bacterial Toxins Associated with Sepsis

In the Past Year, Sigyn Therapy™ Has Been Validated to Address a Broad-Spectrum of Inflammatory Mediators, Gram-Negative Bacterial Toxins, Gram-Positive...

SIGY : 6.3400 (+10.26%)
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand...

AZ.TO : 6.19 (unch)
AAZZF : 10.8545 (+0.13%)
ACST : 2.90 (-0.97%)
ATNM : 6.89 (+5.03%)
ADCO.TO : 0.2500 (unch)
ADCOF : 0.1818 (+13.55%)
ALIM : 3.49 (+5.44%)
ACOGF : 0.5100 (+3.03%)
AMST : 3.27 (-6.57%)
ANVS : 17.75 (+30.51%)
ANPC : 4.37 (-5.41%)
ARC : 2.74 (unch)
Sigyn Therapeutics Featured on National Public Radio: “Addressing the Cytokine Storm”

SAN DIEGO, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory...

SIGY : 6.3400 (+10.26%)
Sigyn Therapeutics CEO Note: A Treatment Candidate to Address Bloodstream Pathogens, Deadly Toxins and Inflammatory Disease Targets

SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTC Markets: SIGY ), a medical technology company focused on the treatment of sepsis and other life-threatening...

SIGY : 6.3400 (+10.26%)

Business Summary

Sigyn Therapeutics Inc. is a medical technology company. It is focused on the treatment of life-threatening inflammatory conditions. Sigyn Therapeutics Inc., formerly knonw as Reign Resources Corporation, is headquartered in San Diego, California USA.

See More

Key Turning Points

3rd Resistance Point 5.7500
2nd Resistance Point 5.7500
1st Resistance Point 5.7500
Last Price 6.3400
1st Support Level 5.7500
2nd Support Level 5.7500
3rd Support Level 5.7500

See More

52-Week High 12.8000
Fibonacci 61.8% 8.7050
Fibonacci 50% 7.4400
Last Price 6.3400
Fibonacci 38.2% 6.1750
52-Week Low 2.0800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar